ACTA PHARMACOLOGICA SINICA

Submitted on September 8th, received first review comments on September 30th, given two months for major revisions. One reviewer provided mild comments, while the other raised 14 questions, most of which required additional experiments. Revised version was submitted on November 22nd, and after the second review on December 7th, minor revisions were requested. The reviewers were satisfied with the revised manuscript, but two new questions were raised, and some small experiments were added. Revised version was submitted on January 4th. On January 14th, it was notified that the paper would be accepted in principle, but it required proofreading. The editor offered free modifications to the abstract and title, and final acceptance is pending after proofreading. Overall, the reviewers' comments significantly improved the paper, and the efficiency of the journal is high. It is a reputable journal among domestic publications, with promising prospects.

Submit it for revisions for a month, and after a month, revise and directly accept it.

It's okay, the quality of the article is acceptable. It's not good to submit without a certain amount of data.